Alzheimer’s and Parkinson’s have different causes and symptoms, so their treatments differ too—though they do share some approaches for managing dementia.
Alzheimer’s treatment focuses on slowing cognitive decline with medications.
Common drugs include cholinesterase inhibitors like donepezil, rivastigmine, and galantamine. These help boost acetylcholine levels in the brain to improve memory and thinking.
For moderate to severe cases, memantine is often used. It works by regulating glutamate, helping protect brain cells.
Recently approved by the FDA, new immunotherapies like lecanemab and donanemab target beta-amyloid plaques. These are designed to slow early-stage disease progression.
Besides medications, non-drug strategies like 40hz therapy ,cognitive training, behavioral therapy, and lifestyle changes—such as healthy eating, regular exercise, and staying socially active—play a big role in managing symptoms and quality of life.
Parkinson’s treatment mainly addresses movement symptoms.
The most common approach is taking levodopa and related drugs to restore dopamine levels and improve motor control. Other options include dopamine agonists, MAO-B inhibitors, anticholinergics, and amantadine.
When medications aren’t enough, deep brain stimulation (DBS) might be considered. This involves placing electrodes in the brain to help manage motor symptoms.
Researchers are also exploring stem cell and gene therapies, which may offer new solutions in the future.
For cognitive symptoms in Parkinson’s dementia, cholinesterase inhibitors—the same drugs used in Alzheimer’s—can be helpful.
Supportive therapies like physical, occupational, and speech therapy are also key in helping patients maintain independence and quality of life.